Provided by Tiger Trade Technology Pte. Ltd.

Xtant Medical

0.5913
+0.02133.74%
Post-market: 0.59130.00000.00%18:17 EST
Volume:348.13K
Turnover:209.61K
Market Cap:82.78M
PE:59.13
High:0.6600
Open:0.6600
Low:0.5710
Close:0.5700
52wk High:0.9500
52wk Low:0.3401
Shares:140.00M
Float Shares:38.07M
Volume Ratio:2.05
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0100
EPS(LYR):-0.1231
ROE:3.64%
ROA:3.87%
PB:1.64
PE(LYR):-4.80

Loading ...

Adagio Medical Unveils Promising Results for Ultralow Temperature Ablation in Ventricular Tachycardia Study

Reuters
·
Feb 04

Adagio Medical Holdings to Participate at BTIG Annual MedTech Conference

Reuters
·
Feb 02

Retrieve Medical Launches Retrieve Passport for Global Medical Record Access

Reuters
·
Jan 20

Xtant Medical Extends Note Maturity After Asset Divestitures

TIPRANKS
·
Jan 17

Xtant Medical Extends Payment Terms in Sale of Coflex, CoFix, and Paradigm Spine Assets to Companion Spine

Reuters
·
Jan 17

Adagio Medical Names Marie-Claude Jacques and Antwan Gipson to Senior Leadership Roles

Reuters
·
Dec 22, 2025

Adagio Medical Holdings CFO Deborah Kaster Acquires Common Shares

Reuters
·
Dec 18, 2025

Adagio Medical Holdings CEO Todd Usen Acquires Common Shares

Reuters
·
Dec 16, 2025

Xtant Medical Launches Next-Generation nanOss Strata Synthetic Bone Graft

Reuters
·
Dec 11, 2025

Adagio Medical Holdings Appoints Sean Salmon to Board of Directors

Reuters
·
Dec 11, 2025

Xtant Medical Completes Sale of Coflex Assets and Paradigm OUS Businesses to Companion Spine

Reuters
·
Dec 02, 2025

Xtant Medical Q3 Revenue USD 33.3 Million

Reuters
·
Nov 20, 2025

Adagio Medical Holdings posts Q3 net loss of $10.1 million

Reuters
·
Nov 13, 2025

Xtant Medical Holdings’ Earnings Call: Positive Growth Amid Challenges

TIPRANKS
·
Nov 12, 2025

Xtant Medical Holdings Is Maintained at Buy by BTIG

Dow Jones
·
Nov 12, 2025

Xtant Medical Holdings: Buy Rating Affirmed on Strong Financial Performance and Strategic Growth Potential

TIPRANKS
·
Nov 11, 2025

Xtant Medical price target lowered to $1.50 from $2 at BTIG

TIPRANKS
·
Nov 11, 2025

Xtant Medical reports Q3 EPS 1c vs. (4c) last year

TIPRANKS
·
Nov 11, 2025

Xtant Medical still sees 2025 revenue $131M-$135M vs. $117.27M in 2024

TIPRANKS
·
Nov 11, 2025

BRIEF-Xtant Medical Q3 Revenue USD 33.3 Million

Reuters
·
Nov 11, 2025